Waring JF - Search Results

1

Identification of proteasome gene regulation in a rat model for HIV protease inhibitor-induced hyperlipidemia.

Waring JF, Ciurlionis R, Marsh K, Klein LL, Degoey DA, Randolph JT, Spear B, Kempf DJ. Waring JF, et al. Arch Toxicol. 2010 Apr;84(4):263-70. doi: 10.1007/s00204-010-0527-7. Epub 2010 Mar 6. Arch Toxicol. 2010. PMID: 20213465

2

Liver transcriptomic changes associated with ritonavir-induced hyperlipidemia in sensitive and resistant strains of rats.

Yang Y, Dahly-Vernon AJ, Blomme EA, Lai-Zhang J, Kempf DJ, Marsh KC, Harrington YA, Nye SH, Evans DL, Roman RJ, Jacob HJ, Waring JF. Yang Y, et al. Among authors: waring jf. Vet J. 2010 Jul;185(1):75-82. doi: 10.1016/j.tvjl.2010.04.017. Epub 2010 May 23. Vet J. 2010. PMID: 20547082

3

Practical preclinical model for assessing the potential for unconjugated hyperbilirubinemia produced by human immunodeficiency virus protease inhibitors.

Kempf DJ, Waring JF, Morfitt DC, Werner P, Ebert B, Mitten M, Nguyen B, Randolph JT, DeGoey DA, Klein LL, Marsh K. Kempf DJ, et al. Among authors: waring jf. Antimicrob Agents Chemother. 2006 Feb;50(2):762-4. doi: 10.1128/AAC.50.2.762-764.2006. Antimicrob Agents Chemother. 2006. PMID: 16436740 Free PMC article.

4

Development of a toxicogenomics in vitro assay for the efficient characterization of compounds.

Yang Y, Abel SJ, Ciurlionis R, Waring JF. Yang Y, et al. Among authors: waring jf. Pharmacogenomics. 2006 Mar;7(2):177-86. doi: 10.2217/14622416.7.2.177. Pharmacogenomics. 2006. PMID: 16515397

5

A human immunodeficiency virus protease inhibitor is a novel functional inhibitor of human pregnane X receptor.

Healan-Greenberg C, Waring JF, Kempf DJ, Blomme EA, Tirona RG, Kim RB. Healan-Greenberg C, et al. Among authors: waring jf. Drug Metab Dispos. 2008 Mar;36(3):500-7. doi: 10.1124/dmd.107.019547. Epub 2007 Dec 20. Drug Metab Dispos. 2008. PMID: 18096673

6

Evaluation of the effects of serial phlebotomy on the transcriptome of major tissues and on the response to toxicants in rats.

Blomme EA, Ciurlionis R, Marsh KC, Waring JF, Yang Y. Blomme EA, et al. Among authors: waring jf. Toxicol Lett. 2008 Jan 30;176(2):138-48. doi: 10.1016/j.toxlet.2007.09.014. Epub 2007 Oct 9. Toxicol Lett. 2008. PMID: 18164877

7

Identifying toxic mechanisms using DNA microarrays: evidence that an experimental inhibitor of cell adhesion molecule expression signals through the aryl hydrocarbon nuclear receptor.

Waring JF, Gum R, Morfitt D, Jolly RA, Ciurlionis R, Heindel M, Gallenberg L, Buratto B, Ulrich RG. Waring JF, et al. Toxicology. 2002 Dec 27;181-182:537-50. doi: 10.1016/s0300-483x(02)00477-8. Toxicology. 2002. PMID: 12505364

8

Isolated human hepatocytes in culture display markedly different gene expression patterns depending on attachment status.

Waring JF, Ciurlionis R, Jolly RA, Heindel M, Gagne G, Fagerland JA, Ulrich RG. Waring JF, et al. Toxicol In Vitro. 2003 Oct-Dec;17(5-6):693-701. doi: 10.1016/s0887-2333(03)00102-4. Toxicol In Vitro. 2003. PMID: 14599465

9

Microvesicular steatosis induced by a short chain fatty acid: effects on mitochondrial function and correlation with gene expression.

Jolly RA, Ciurlionis R, Morfitt D, Helgren M, Patterson R, Ulrich RG, Waring JF. Jolly RA, et al. Among authors: waring jf. Toxicol Pathol. 2004 Jul-Aug;32 Suppl 2:19-25. doi: 10.1080/01926230490451699. Toxicol Pathol. 2004. PMID: 15503661

10

Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity.

Waring JF, Ciurlionis R, Jolly RA, Heindel M, Ulrich RG. Waring JF, et al. Toxicol Lett. 2001 Mar 31;120(1-3):359-68. doi: 10.1016/s0378-4274(01)00267-3. Toxicol Lett. 2001. PMID: 11323195

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

89 results

Search Page